Technology
Amcor reports fiscal 2024 results and provides outlook for fiscal 2025
Published
3 months agoon
By
June 2024 Quarter Highlights:
Another sequential improvement in volumes and earnings growth;Net sales of $3,535 million; volumes returned to growth, up 1%;GAAP net income of $257 million; GAAP diluted earnings per share (EPS) of 17.8 cps;Adjusted EBIT of $454 million, up 4% on a comparable constant currency basis; andAdjusted EPS of 21.1 cps, up 9% on a comparable constant currency basis.
Fiscal 2024 Full Year Highlights:
Net sales of $13,640 million;GAAP Net Income of $730 million; GAAP diluted EPS of 50.5 cps;Adjusted EPS of 70.2 cps and Adjusted EBIT of $1,560 million;Adjusted Free Cash Flow of $952 million, up >$100 million or 12% on last year; andCash returns to shareholders of approximately $750 million: annual dividend increased to 50.0 cents per share and $30 million of shares repurchased.
Fiscal 2025 outlook:
Adjusted EPS of 72-76 cents per share; Adjusted Free Cash Flow of $900-1,000 million.
ZURICH, Aug. 15, 2024 /PRNewswire/ —
Strong 4Q financial performance ahead of expectations with volumes returning to growth
Amcor expects strong growth from the underlying business to continue in FY25
Amcor Interim CEO Peter Konieczny said: “Amcor finished fiscal 2024 strongly, as the underlying business delivered another sequential improvement in volume and earnings growth, with fourth quarter adjusted EPS up 9%, ahead of the expectations we set out in April. Volumes returned to year on year growth in the quarter as customer demand improved and our teams maintained their outstanding focus on managing costs, driving strong margin expansion. Annual adjusted free cash flow was at the top end of our guidance range and up 12% on last year.
In fiscal 2025, we expect volumes and earnings will grow and adjusted free cash flow will remain strong. Importantly, combined with our historical average dividend yield, growth at the midpoint of our EPS guidance range results in total value creation in-line with our shareholder value creation model 10-15% range.
We remain confident in our capital allocation framework and strategy for long term growth. We believe our underlying business and market positions are strong and we will continue to invest for organic growth, pursue acquisitions or repurchase shares and return cash to shareholders through a compelling and growing dividend.”
Key Financials(1)
Twelve Months Ended June 30,
GAAP results
2023 $ million
2024 $ million
Net sales
14,694
13,640
Net income
1,048
730
EPS (diluted US cents)
70.5
50.5
Twelve Months Ended June 30,
Reported ∆%
Comparable
constant
currency ∆%
Adjusted non-GAAP results
2023 $ million
2024 $ million
Net sales
14,694
13,640
(7)
(6)
EBITDA
2,018
1,962
(3)
(1)
EBIT
1,608
1,560
(3)
(1)
Net income
1,089
1,015
(7)
(5)
EPS (diluted US cents)
73.3
70.2
(4)
(2)
Free Cash Flow
848
952
(1) Adjusted non-GAAP results exclude items which are not considered representative of ongoing operations. Comparable constant currency ∆% excludes the impact of movements in foreign exchange rates and items affecting comparability. Further details related to non-GAAP measures and reconciliations to GAAP measures can be found under “Presentation of non-GAAP information” in this release.
Note: All amounts referenced throughout this document are in US dollars unless otherwise indicated and numbers may not add up precisely to the totals provided due to rounding.
Shareholder returns
Capital allocation
Amcor generates significant annual cash flow and is committed to an investment grade credit rating. We believe that the Company’s strong annual cash flow and balance sheet provide capacity to reinvest in the business for organic growth, pursue acquisitions or share repurchases and return cash to shareholders through a compelling and growing dividend.
During fiscal 2024, the Company returned approximately $750 million to shareholders through cash dividends and share repurchases.
Dividend
The Amcor Board of Directors today declared a quarterly cash dividend of 12.5 cents per share (compared with 12.25 cents per share in the same quarter last year). Combined with the last three quarterly dividends, this increases the annual dividend for fiscal 2024 to 50.0 cents per share. The quarterly dividend declared today will be paid in US dollars to holders of Amcor’s ordinary shares trading on the NYSE. Holders of CDIs trading on the ASX will receive an unfranked dividend of 19.01 Australian cents per share, which reflects the quarterly dividend of 12.5 cents per share converted at an average AUD:USD exchange rate of 0.6574 over the five trading days ended August 13, 2024.
The ex-dividend date will be September 5, 2024, the record date will be September 6, 2024, and the payment date will be September 26, 2024.
Share repurchases
Amcor repurchased approximately 3 million shares during fiscal 2024 for a total cost of approximately $30 million.
Financial results – twelve months ended June 30, 2024
Segment Information
Twelve Months Ended June 30, 2023
Twelve Months Ended June 30, 2024
Adjusted non-GAAP
results
Net sales
$ million
EBIT
$ million
EBIT /
Sales %
EBIT / Average
funds employed
%(1)
Net sales
$ million
EBIT
$ million
EBIT /
Sales %
EBIT / Average
funds employed
%(1)
Flexibles
11,154
1,429
12.8
10,332
1,395
13.5
Rigid Packaging
3,540
265
7.5
3,308
259
7.8
Other(2)
—
(86)
—
(94)
Total Amcor
14,694
1,608
10.9
15.4
13,640
1,560
11.4
14.9
(1) Return on average funds employed includes shareholders’ equity and net debt, calculated using a four quarter average and last twelve months adjusted EBIT.
(2) Represents corporate expenses.
Twelve months ended June 30, 2024:
Net sales of $13,640 million were 7% lower than last year on a reported basis, including a favorable impact of approximately 1% related to movements in foreign exchange rates, an unfavorable impact of approximately 1% related to items affecting comparability, and an unfavorable impact of 1% related to the pass through of lower raw material costs of approximately $220 million.
Net sales on a comparable constant currency basis were 6% lower than last year reflecting approximately 5% lower volumes and an unfavorable price/mix impact of approximately 1%.
Adjusted EBIT of $1,560 million was 1% lower than last year on a comparable constant currency basis, reflecting lower volumes and unfavorable impacts from price/mix, partly offset by strong cost performance.
June 2024 quarter result:
Net sales of $3,535 million were 4% lower than last year on a reported basis, including an unfavorable impact of 2% related to the pass through of lower raw material costs of approximately $70 million. Movements in foreign exchange rates had an unfavorable impact on net sales of less than 1% for the quarter.
Volumes returned to growth in the June quarter, up approximately 1% compared with the prior year which represents a sequential improvement of 5 percentage points. As expected, volumes remained soft in healthcare categories and in the North America beverage business through the June quarter, unfavorably impacting overall volumes by approximately 2%. Price/mix had an unfavorable impact of approximately 3% due to lower volumes in high value healthcare categories. On a comparable constant currency basis, net sales were 1% lower than last year.
Adjusted EBIT of $454 million was approximately 4% higher than last year on a comparable constant currency basis. Unfavorable impacts from price/mix were more than offset by higher volumes, benefits from restructuring initiatives and continued outstanding cost performance which resulted in strong earnings leverage.
Flexibles segment – June 2024 quarter
Three Months Ended June 30,
Reported
∆%
Comparable
constant
currency ∆%
2023 $ million
2024 $ million
Net sales
2,777
2,686
(3)
(1)
Adjusted EBIT
387
403
4
5
Adjusted EBIT / Sales %
13.9
15.0
Net sales of $2,686 million were 3% lower than last year on a reported basis, including an unfavorable impact of approximately 1% related to movements in foreign exchange rates and an unfavorable impact of 1% related to the pass through of lower raw material costs of approximately $40 million.
Volumes returned to growth in the June quarter, up approximately 3% compared with the prior year, which is a sequential improvement of 5 percentage points. Price/mix had an unfavorable impact of approximately 4%, primarily due to lower volumes in high value healthcare categories. On a comparable constant currency basis, net sales were 1% lower than last year.
Volumes were higher than the same quarter last year across most geographies and in several end markets including home & personal care, meat, cheese and unconverted film and foil. As expected, destocking continued in healthcare categories and volumes remained soft, unfavorably impacting overall segment volumes for the quarter by approximately 2%.
Adjusted EBIT of $403 million was 5% higher than last year on a comparable constant currency basis. The impact of higher volumes, benefits from restructuring initiatives and strong cost performance was partly offset by unfavorable price/mix. Earnings leverage was strong, and adjusted EBIT margin of 15.0% was 110 basis points higher than the June quarter last year.
Flexibles segment – Fiscal 2024
Twelve Months Ended June 30,
Reported
∆%
Comparable
constant
currency ∆%
2023 $ million
2024 $ million
Net sales
11,154
10,332
(7)
(6)
Adjusted EBIT
1,429
1,395
(2)
—
Adjusted EBIT / Sales %
12.8
13.5
Net sales of $10,332 million were 7% lower than last year on a reported basis, including a favorable impact of approximately 1% related to movements in foreign exchange rates, an unfavorable impact of approximately 1% related to items affecting comparability and an unfavorable impact of 1% related to the pass through of lower raw material costs of approximately $180 million. On a comparable constant currency basis, net sales were 6% lower, reflecting an unfavorable price/mix impact of approximately 2% and lower volumes of approximately 4%. Volume weakness largely reflects lower market and customer demand and destocking particularly through the first half of the year. The trajectory of volumes improved significantly through the second half of the year, returning to year over year growth in the June quarter.
In North America, net sales declined at mid to high single digit rates driven by lower volumes and an unfavorable price/mix impact. Volumes were higher in the condiments, snacks and cheese categories and this was more than offset by lower volumes in categories including healthcare, meat and liquid beverage.
In Europe, net sales declined at high single digit rates primarily driven by lower volumes. Volumes were lower mainly in the healthcare, snacks & confectionary, coffee and yoghurt end markets.
Across the Asian region, volumes were higher than the prior year with growth in Thailand, India and China, partly offset by lower volumes in the South East Asian healthcare business. In Latin America, net sales declined at mid single digit rates, driven by lower volumes mainly in Chile and Mexico, partly offset by growth in Brazil.
Adjusted EBIT of $1,395 million was in line with last year on a comparable constant currency basis, reflecting lower volumes and unfavorable impacts from price/mix, partly offset by benefits from restructuring initiatives and ongoing actions taken to lower costs and increase productivity. Adjusted EBIT margin of 13.5% was higher than the prior year notwithstanding weaker volumes and a 30 basis point unfavorable impact compared to the prior year related to the sale of the Russian business in December 2022.
Rigid Packaging segment – June 2024 quarter
Three Months Ended June 30,
Reported
∆%
Comparable
constant
currency ∆%
2023 $ million
2024 $ million
Net sales
897
849
(5)
(2)
Adjusted EBIT
73
75
3
2
Adjusted EBIT / Sales %
8.1
8.8
Net sales of $849 million were 5% lower than last year on a reported basis, including an unfavorable impact of 4% related to the pass through of lower raw material costs of approximately $30 million. Movements in foreign exchange rates had a favorable impact on net sales of less than 1% for the quarter.
On a comparable constant currency basis, net sales were 2% lower than last year with volumes approximately 5% lower, partly offset by favorable price/mix benefits of approximately 3%.
In North America, overall beverage volumes improved sequentially for the second consecutive quarter. While consumer and customer demand in key categories improved sequentially, overall volumes were 8% lower as a result of continued soft demand which was expected. Hot fill beverage container volumes were 9% lower than the same quarter last year, which represents a 9 percentage point improvement compared with the March 2024 quarter.
In Latin America, volumes were 3% higher than the same quarter last year, reflecting new business wins in Brazil, Colombia and Central America, partly offset by weaker demand in Argentina. Specialty Container volumes were lower than last year.
Adjusted EBIT of $75 million was 2% higher than last year on a comparable constant currency basis, with the impact of lower volumes more than offset by favorable price/mix, benefits from restructuring initiatives and strong cost performance which drove solid earnings leverage.
Rigid Packaging segment – Fiscal 2024
Twelve Months Ended June 30,
Reported
∆%
Comparable
constant
currency ∆%
2023 $ million
2024 $ million
Net sales
3,540
3,308
(7)
(6)
Adjusted EBIT
265
259
(2)
(4)
Adjusted EBIT / Sales %
7.5
7.8
Net sales of $3,308 million were 7% lower than last year on a reported basis, including an unfavorable impact of 1% related to the pass through of lower raw material costs of approximately $40 million. Movements in foreign exchange rates had a favorable impact on net sales of less than 1%. On a comparable constant currency basis, net sales were 6% lower than last year, reflecting price/mix benefits of approximately 2% and volumes were approximately 8% lower than last year.
In North America, overall beverage volumes were 12% lower than last year, including a reduction in hot fill beverage container volumes of approximately 13%. This mainly reflects a combination of lower consumer and customer demand, as well as significant destocking particularly through the first half of the year.
In Latin America, volumes were 3% higher than last year, reflecting new business wins with a broad range of customers in Brazil and Colombia, partly offset by lower volumes in Argentina. Specialty Container volumes were lower than last year.
Adjusted EBIT of $259 million was 4% lower than last year on a comparable constant currency basis, reflecting lower volumes partly offset by price/mix benefits and favorable cost performance.
Net interest and income tax expense
For the year ended June 30, 2024, net interest expense of $310 million was $51 million higher than last year, reflecting higher interest rates. GAAP income tax expense was $163 million compared with $193 million last year. Adjusted tax expense for the year ended June 30, 2024 was $225 million compared with $250 million last year. Adjusted tax expense for the year ended June 30, 2024 represents an effective tax rate of 18.0%, compared with 18.5% in the prior year.
Adjusted Free Cash Flow
For the year ended June 30, 2024, adjusted free cash inflow was $952 million, at the top end of the Company’s guidance range and up $104 million, or 12% compared with the prior year.
Net debt was $6,111 million at June 30, 2024. Leverage, measured as net debt divided by adjusted trailing twelve month EBITDA, was 3.1 times and in line with our expectations.
Fiscal 2025 Guidance
For the twelve month period ending June 30, 2025, the Company expects:
Adjusted EPS of approximately 72 to 76 cents per share, which represents comparable constant currency growth of 3% to 8% (includes approximately 4% headwind related to normalization of incentive compensation payments) compared with 70.2 cents per share in fiscal 2024.Assuming current exchange rates prevail through fiscal 2025, movements in exchange rates are not expected to have a material impact on reported EPS.Adjusted Free Cash Flow of approximately $900 million to $1,000 million.
Amcor’s guidance contemplates a range of factors which create a degree of uncertainty and complexity when estimating future financial results. Further information can be found under ‘Cautionary Statement Regarding Forward-Looking Statements’ in this release.
Conference Call
Amcor is hosting a conference call with investors and analysts to discuss these results on Thursday August 15, 2024 at 5:30pm US Eastern Daylight Time / Friday August 16, 2024 at 7:30am Australian Eastern Standard Time. Investors are invited to listen to a live webcast of the conference call at our website, www.amcor.com, in the “Investors” section.
Those wishing to access the call should use the following toll-free numbers, with the Conference ID : 9115937
USA: 800 715 9871 (toll free)USA: 646 307 1963 (local)Australia: 1800 519 630 (toll free), 02 9133 7103 (local)United Kingdom: 0800 358 0970 (toll free), 020 3433 3846 (local)Singapore: +65 3159 5133 (local)Hong Kong: +852 3002 3410 (local)
From all other countries, the call can be accessed by dialing +1 646 307 1963 (toll).
A replay of the webcast will also be available in the ‘Investors” section at www.amcor.com following the call.
About Amcor
Amcor is a global leader in developing and producing responsible packaging solutions across a variety of materials for food, beverage, pharmaceutical, medical, home and personal-care, and other products. Amcor works with leading companies around the world to protect products, differentiate brands, and improve supply chains. The Company offers a range of innovative, differentiating flexible and rigid packaging, specialty cartons, closures and services. The company is focused on making packaging that is increasingly recyclable, reusable, lighter weight and made using an increasing amount of recycled content. In fiscal year 2024, 41,000 Amcor people generated $13.6 billion in annual sales from operations that span 212 locations in 40 countries. NYSE: AMCR; ASX: AMC
www.amcor.com I LinkedIn I YouTube
Contact Information
Investors
Tracey Whitehead
Damien Bird
Damon Wright
Global Head of Investor Relations
Vice President Investor Relations Asia Pacific
Vice President Investor Relations North America
Amcor
Amcor
Amcor
+61 408 037 590
+61 481 900 499
+1 224 313 7141
Media – Australia
Media – Europe
Media – North America
James Strong
Ernesto Duran
Julie Liedtke
Managing Director
Head of Global Communications
Director, Media Relations
Sodali & Co
Amcor
Amcor
+61 448 881 174
+41 78 698 69 40
+1 847 204 2319
Amcor plc UK Establishment Address: 83 Tower Road North, Warmley, Bristol, England, BS30 8XP, United Kingdom
UK Overseas Company Number: BR020803
Registered Office: 3rd Floor, 44 Esplanade, St Helier, JE4 9WG, Jersey
Jersey Registered Company Number: 126984, Australian Registered Body Number (ARBN): 630 385 278
Cautionary Statement Regarding Forward-Looking Statements
This document contains certain statements that are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like “believe,” “expect,” “target,” “project,” “may,” “could,” “would,” “approximately,” “possible,” “will,” “should,” “intend,” “plan,” “anticipate,” “commit,” “estimate,” “potential,” “ambitions,” “outlook,” or “continue,” the negative of these words, other terms of similar meaning, or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. Neither Amcor nor any of its respective directors, executive officers, or advisors provide any representation, assurance, or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to: changes in consumer demand patterns and customer requirements in numerous industries; the loss of key customers, a reduction in their production requirements or consolidation among key customers; significant competition in the industries and regions in which we operate; an inability to expand our current business effectively through either organic growth, including product innovation, investments or acquisitions; challenging global economic conditions, impacts of operating internationally; price fluctuations or shortages in the availability of raw materials, energy, and other inputs which could adversely affect our business; production, supply, and commercial risks, including counterparty credit risks, which may be exacerbated in times of economic volatility; pandemics, epidemics, or other disease outbreaks; an inability to attract, motivate and retain our skilled workforce and manage key transitions; labor disputes and an inability to renew collective bargaining agreements at acceptable terms; physical impact of climate change; cybersecurity risks, which could disrupt our operations or risk of loss of our sensitive business information; failures or disruptions in our information technology systems which could disrupt our operations, compromise customer, employee, supplier and other data; a significant increase in our indebtedness or a downgrade in our credit rating could reduce our operating flexibility and increase our borrowing costs and negatively affect our financial condition and results of operations; rising interest rates that increase our borrowing costs on our variable rate indebtedness and could have other negative impacts; foreign exchange rate risk; a significant write-down of goodwill and/or intangible assets; a failure to maintain an effective system of internal control over financial reporting; inability of our insurance policies, including our use of a captive insurance company, to provide adequate protection against all of the risks we face; an inability to defend our intellectual property rights or intellectual property infringement claims against us; litigation, including product liability claims or litigation related to Environmental, Social, and Governance (“ESG”) matters or regulatory developments; increasing scrutiny and changing expectations from investors, customers, suppliers and governments with respect to our ESG practices and commitments resulting in additional costs or exposure to additional risks; changing ESG disclosure regulations including climate-related rules; changing environmental, health, and safety laws; changes in tax laws or changes in our geographic mix of earnings; and other risks and uncertainties identified from time to time in Amcor’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including without limitation, those described under Item 1A. “Risk Factors” of Amcor’s annual report on Form 10-K for the fiscal year ended June 30, 2023 and any subsequent quarterly reports on Form 10-Q. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor assumes no obligation, and disclaims any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
Presentation of non-GAAP information
Included in this release are measures of financial performance that are not calculated in accordance with U.S. GAAP. These measures include adjusted EBITDA and EBITDA (calculated as earnings before interest and tax and depreciation and amortization), adjusted EBIT and EBIT (calculated as earnings before interest and tax), adjusted net income, adjusted earnings per share, adjusted free cash flow and net debt. In arriving at these non-GAAP measures, we exclude items that either have a non-recurring impact on the income statement or which, in the judgment of our management, are items that, either as a result of their nature or size, could, were they not singled out, potentially cause investors to extrapolate future performance from an improper base. Note that while amortization of acquired intangible assets is excluded from non-GAAP adjusted financial measures, the revenue of the acquired entities and all other expenses unless otherwise stated, are reflected in our non-GAAP financial performance earnings measures. While not all inclusive, examples of these items include: material restructuring programs, including associated costs such as employee severance, pension and related benefits, impairment of property and equipment and other assets, accelerated depreciation, termination payments for contracts and leases, contractual obligations, and any other qualifying costs related to restructuring plans; material sales and earnings from disposed or ceased operations and any associated profit or loss on sale of businesses or subsidiaries; changes in the fair value of economic hedging instruments on commercial paper and contingent purchase consideration; significant pension settlements; impairments in goodwill and equity method investments; material acquisition compensation and transaction costs such as due diligence expenses, professional and legal fees, and integration costs; material purchase accounting adjustments for inventory; amortization of acquired intangible assets from business combination; gains or losses on significant property and divestitures and significant property and other impairments, net of insurance recovery; certain regulatory and legal matters; impacts from highly inflationary accounting; expenses related to the Company’s Chief Executive Officer transition; and impacts related to the Russia–Ukraine conflict.
Amcor also evaluates performance on a comparable constant currency basis, which measures financial results assuming constant foreign currency exchange rates used for translation based on the average rates in effect for the comparable prior year period. In order to compute comparable constant currency results, we multiply or divide, as appropriate, current-year U.S. dollar results by the current year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior-year average foreign exchange rates. We then adjust for other items affecting comparability. While not all inclusive, examples of items affecting comparability include the difference between sales or earnings in the current period and the prior period related to disposed, or ceased operations. Comparable constant currency net sales performance also excludes the impact from passing through movements in raw material costs.
Management has used and uses these measures internally for planning, forecasting and evaluating the performance of the Company’s reporting segments and certain of the measures are used as a component of Amcor’s Board of Directors’ measurement of Amcor’s performance for incentive compensation purposes. Amcor believes that these non-GAAP measures are useful to enable investors to perform comparisons of current and historical performance of the Company. For each of these non-GAAP financial measures, a reconciliation to the most directly comparable U.S. GAAP financial measure has been provided herein. These non-GAAP financial measures should not be construed as an alternative to results determined in accordance with U.S. GAAP. The Company provides guidance on a non-GAAP basis as we are unable to predict with reasonable certainty the ultimate outcome and timing of certain significant forward-looking items without unreasonable effort. These items include but are not limited to the impact of foreign exchange translation, restructuring program costs, asset impairments, possible gains and losses on the sale of assets, and certain tax related events. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP earnings and cash flow measures for the guidance period.
Dividends
Amcor has received a waiver from the ASX’s settlement operating rules, which will allow the Company to defer processing conversions between its ordinary share and CDI registers from September 5, 2024 to September 6, 2024 inclusive.
U.S. GAAP Condensed Consolidated Statements of Income (Unaudited)
Three Months Ended June 30,
Twelve Months Ended June 30,
($ million, except per share amounts)
2023
2024
2023
2024
Net sales
3,673
3,535
14,694
13,640
Cost of sales
(2,951)
(2,781)
(11,969)
(10,928)
Gross profit
722
754
2,725
2,712
Selling, general, and administrative expenses
(329)
(329)
(1,246)
(1,260)
Research and development expenses
(25)
(26)
(101)
(106)
Restructuring and other related activities, net
(59)
(15)
104
(97)
Other income/(expense), net
16
11
26
(35)
Operating income
325
395
1,508
1,214
Interest expense, net
(70)
(78)
(259)
(310)
Other non-operating income/(expense), net
(3)
1
2
3
Income before income taxes and equity in loss of affiliated
companies
252
318
1,251
907
Income tax expense
(68)
(56)
(193)
(163)
Equity in loss of affiliated companies, net of tax
—
(1)
—
(4)
Net income
184
261
1,058
740
Net income attributable to non-controlling interests
(4)
(4)
(10)
(10)
Net income attributable to Amcor plc
181
257
1,048
730
USD:EUR average FX rate
0.9185
0.9287
0.9561
0.9245
Basic earnings per share attributable to Amcor
0.124
0.178
0.709
0.505
Diluted earnings per share attributable to Amcor
0.123
0.178
0.705
0.505
Weighted average number of shares outstanding – Basic
1,452
1,439
1,468
1,439
Weighted average number of shares outstanding – Diluted
1,456
1,443
1,476
1,441
U.S. GAAP Condensed Consolidated Statements of Cash Flows (Unaudited)
Twelve Months Ended June 30,
($ million)
2023
2024
Net income
1,058
740
Depreciation, amortization, and impairment
586
595
Net gain on disposal of businesses and investments
(220)
—
Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and
currency
(265)
(120)
Other non-cash items
102
106
Net cash provided by operating activities
1,261
1,321
Purchase of property, plant, and equipment and other intangible assets
(526)
(492)
Proceeds from sales of property, plant, and equipment and other intangible assets
30
39
Business acquisitions and Investments in affiliated companies, and other
(177)
(23)
Proceeds from divestitures
365
—
Net debt proceeds/(repayments)
228
(43)
Dividends paid
(723)
(722)
Share buy-back/cancellations
(432)
(30)
Purchase of treasury shares and tax withholdings for share-based incentive plans
(87)
(51)
Other, including effects of exchange rate on cash and cash equivalents
(100)
(100)
Net decrease in cash and cash equivalents
(161)
(101)
Cash and cash equivalents at the beginning of the year(1)
850
689
Cash and cash equivalents at the end of the period
689
588
(1) Cash and cash equivalents at the beginning of fiscal 2023 includes $75 million of cash and cash equivalents as held for sale.
U.S. GAAP Condensed Consolidated Balance Sheets (Unaudited)
($ million)
June 30, 2023
June 30, 2024
Cash and cash equivalents
689
588
Trade receivables, net
1,875
1,846
Inventories, net
2,213
2,031
Property, plant and equipment, net
3,762
3,763
Goodwill and other intangible assets, net
6,890
6,736
Other assets
1,574
1,560
Total assets
17,003
16,524
Trade payables
2,690
2,580
Short-term debt and current portion of long-term debt
93
96
Long-term debt, less current portion
6,653
6,603
Accruals and other liabilities
3,477
3,292
Shareholders’ equity
4,090
3,953
Total liabilities and shareholders’ equity
17,003
16,524
Components of Fiscal 2024 Net Sales growth
Three Months Ended June 30
Twelve Months Ended June 30
($ million)
Flexibles
Rigid
Packaging
Total
Flexibles
Rigid
Packaging
Total
Net sales fiscal year 2024
2,686
849
3,535
10,332
3,308
13,640
Net sales fiscal year 2023
2,777
897
3,673
11,154
3,540
14,694
Reported Growth %
(3)
(5)
(4)
(7)
(7)
(7)
FX %
(1)
—
(1)
1
—
1
Constant Currency Growth %
(2)
(6)
(3)
(8)
(7)
(8)
Raw Material Pass Through %
(1)
(4)
(2)
(1)
(1)
(1)
Items affecting comparability %
—
—
—
(1)
—
(1)
Comparable Constant Currency
Growth %
(1)
(2)
(1)
(6)
(6)
(6)
Acquired Operations %
—
—
—
—
—
—
Organic Growth
(1)
(2)
(1)
(6)
(6)
(6)
Volume %
3
(5)
1
(4)
(8)
(5)
Price/Mix %
(4)
3
(3)
(2)
2
(1)
Reconciliation of Non-GAAP Measures
Reconciliation of adjusted Earnings before interest, tax, depreciation and amortization (EBITDA), Earnings before interest
and tax (EBIT), Net income, Earnings per share (EPS) and Free Cash Flow
Three Months Ended June 30, 2023
Three Months Ended June 30, 2024
($ million)
EBITDA
EBIT
Net
Income
EPS
(Diluted
US
cents)(1)
EBITDA
EBIT
Net
Income
EPS
(Diluted
US
cents)(1)
Net income attributable to Amcor
181
181
181
12.3
257
257
257
17.8
Net income attributable to non-controlling
interests
4
4
4
4
Tax expense
68
68
56
56
Interest expense, net
70
70
78
78
Depreciation and amortization
144
136
EBITDA, EBIT, Net income and EPS
467
323
181
12.3
531
395
257
17.8
Impact of highly inflationary accounting
5
5
5
0.4
(2)
(2)
(2)
(0.1)
Property and other losses,net
2
2
2
0.1
—
—
—
—
Restructuring and other related activities, net(2)
66
66
66
4.5
15
15
15
1.0
Other
—
—
—
—
(0.1)
5
5
5
0.3
Amortization of acquired intangibles(3)
40
40
2.9
41
41
2.9
Tax effect of above items
(12)
(0.8)
(11)
(0.8)
Adjusted EBITDA, EBIT, Net income, and EPS
540
436
282
19.3
550
454
305
21.1
Reconciliation of adjusted growth to comparable constant currency growth
% growth – Adjusted EBITDA, EBIT, Net income and EPS
2
4
8
9
% items affecting comparability(4)
—
—
—
—
% currency impact
—
—
1
—
% comparable constant currency growth
2
4
9
9
Adjusted EBITDA
540
550
Interest paid, net
(79)
(99)
Income tax paid
(95)
(90)
Purchase of property, plant and equipment and
other intangible assets
(144)
(134)
Proceeds from sales of property, plant and
equipment and other intangible assets
18
27
Movement in working capital
572
610
Other
22
(27)
Adjusted Free Cash Flow
834
837
(1) Calculation of diluted EPS for the three months ended June 30, 2024 excludes net income attributable to shares to be repurchased under
forward contracts of $1 million. Calculation of diluted EPS for the three months ended June 30, 2023 excludes net income attributable to shares to
be repurchased under forward contracts of $1 million.
(2) Includes incremental restructuring and other costs attributable to group wide initiatives to partly offset divested earnings from the Russian
business.
(3) Amortization of acquired intangible assets from business combinations.
(4) Reflects the impact of acquired, disposed, and ceased operations.
Twelve Months Ended June 30, 2023
Twelve Months Ended June 30, 2024
($ million)
EBITDA
EBIT
Net
Income
EPS
(Diluted
US
cents)(1)
EBITDA
EBIT
Net
Income
EPS
(Diluted
US
cents)(1)
Net income attributable to Amcor
1,048
1,048
1,048
70.5
730
730
730
50.5
Net income attributable to non-controlling
interests
10
10
10
10
Tax expense
193
193
163
163
Interest expense, net
259
259
310
310
Depreciation and amortization
569
569
EBITDA, EBIT, Net income and EPS
2,080
1,510
1,048
70.5
1,782
1,213
730
50.5
Impact of highly inflationary accounting
24
24
24
1.9
53
53
53
3.7
Property and other losses, net
2
2
2
0.1
—
—
—
—
Restructuring and other related activities, net(2)
(90)
(90)
(90)
(6.0)
97
97
97
6.7
CEO Transition costs
—
—
—
—
8
8
8
0.6
Other
2
2
2
—
22
22
22
1.5
Amortization of acquired intangibles (3)
160
160
10.8
167
167
11.6
Tax effect of above items
(57)
(4.0)
(62)
(4.4)
Adjusted EBITDA, EBIT, Net income and EPS
2,018
1,608
1,089
73.3
1,962
1,560
1,015
70.2
Reconciliation of adjusted growth to comparable constant currency growth
% growth – Adjusted EBITDA, EBIT, Net income, and EPS
(3)
(3)
(7)
(4)
% items affecting comparability(4)
3
3
3
3
% currency impact
(1)
(1)
(1)
(1)
% comparable constant currency growth
(1)
(1)
(5)
(2)
Adjusted EBITDA
2,018
1,962
Interest paid, net
(248)
(295)
Income tax paid
(225)
(253)
Purchase of property, plant and equipment and
other intangible assets
(526)
(492)
Proceeds from sales of property, plant and
equipment and other intangible assets
30
39
Movement in working capital
(229)
(15)
Other
28
6
Adjusted Free Cash Flow
848
952
(1) Calculation of diluted EPS for the twelve months ended June 30, 2024 excludes net income attributable to shares to be repurchased under forward contracts of $3 million. Calculation of diluted EPS for the twelve months ended June 30, 2023 excludes net income attributable to shares to be repurchased under forward contracts of $7 million.
(2) Includes incremental restructuring and other costs attributable to group wide initiatives to partly offset divested earnings from the Russian business.
(3) Amortization of acquired intangible assets from business combinations.
(4) Reflects the impact of acquired, disposed, and ceased operations.
Reconciliation of adjusted EBIT by reporting segment
Three Months Ended June 30, 2023
Three Months Ended June 30, 2024
($ million)
Flexibles
Rigid
Packaging
Other
Total
Flexibles
Rigid
Packaging
Other
Total
Net income attributable to Amcor
181
257
Net income attributable to non-
controlling interests
4
4
Tax expense
68
56
Interest expense, net
70
78
EBIT
283
62
(22)
323
351
73
(29)
395
Impact of highly inflationary accounting
—
5
—
5
—
(2)
—
(2)
Property and other losses, net
—
—
2
2
—
—
—
—
Restructuring and other related
activities, net(1)
62
2
2
66
11
4
—
15
Other
3
3
(6)
—
—
—
5
5
Amortization of acquired intangibles(2)
39
1
—
40
41
—
—
41
Adjusted EBIT
387
73
(24)
436
403
75
(24)
454
Adjusted EBIT / sales %
13.9 %
8.1 %
11.9 %
15.0 %
8.8 %
12.8 %
Reconciliation of adjusted growth to comparable constant currency growth
% growth – Adjusted EBIT
4
3
—
4
% items affecting comparability(3)
—
—
—
—
% currency impact
1
(1)
—
—
% comparable constant currency
5
2
—
4
(1) Includes incremental restructuring and other costs attributable to group wide initiatives to partly offset divested earnings from the Russian business.
(2) Amortization of acquired intangible assets from business combinations.
(3) Reflects the impact of acquired, disposed, and ceased operations.
Twelve Months Ended June 30, 2023
Twelve Months Ended June 30, 2024
($ million)
Flexibles
Rigid
Packaging
Other
Total
Flexibles
Rigid
Packaging
Other
Total
Net income attributable to Amcor
1,048
730
Net income attributable to non-
controlling interests
10
10
Tax expense
193
163
Interest expense, net
259
310
EBIT
1,357
225
(72)
1,510
1,147
185
(119)
1,213
Impact of highly inflationary
accounting
—
24
—
24
—
53
—
53
Property and other losses, net
—
—
2
2
—
—
—
—
Restructuring and other related
activities, net(1)
(100)
8
2
(90)
79
18
—
97
CEO transition costs
—
—
—
—
—
—
8
8
Other
17
3
(18)
2
5
—
17
22
Amortization of acquired intangibles(2)
155
5
—
160
164
3
—
167
Adjusted EBIT
1,429
265
(86)
1,608
1,395
259
(94)
1,560
Adjusted EBIT / sales %
12.8 %
7.5 %
10.9 %
13.5 %
7.8 %
11.4 %
Reconciliation of adjusted growth to comparable constant currency growth
% growth – Adjusted EBIT
(2)
(2)
—
(3)
% items affecting comparability(3)
3
—
—
3
% currency impact
(1)
(2)
—
(1)
% comparable constant currency growth
—
(4)
—
(1)
(1) Includes incremental restructuring and other costs attributable to group wide initiatives to partly offset divested earnings from the Russian business.
(2) Amortization of acquired intangible assets from business combinations.
(3) Reflects the impact of acquired, disposed, and ceased operations.
Reconciliation of net debt
($ million)
June 30, 2023
June 30, 2024
Cash and cash equivalents
(689)
(588)
Short-term debt
80
84
Current portion of long-term debt
13
12
Long-term debt excluding current portion
6,653
6,603
Net debt
6,057
6,111
View original content:https://www.prnewswire.com/news-releases/amcor-reports-fiscal-2024-results-and-provides-outlook-for-fiscal-2025-302223329.html
SOURCE Amcor
You may like
Technology
Trainocate Wins Cisco Learning Partner of the Year – APJC for Second Consecutive Year
Published
30 minutes agoon
November 15, 2024By
BANGALORE, India, Nov. 15, 2024 /PRNewswire/ — Trainocate Holdings, a leading global provider of technology and business training solutions, today announced that it has been awarded the Cisco Learning Partner of the Year 2024 for Asia Pacific, Japan, and China (APJC) for the second year in a row.
This prestigious award recognizes Trainocate’s outstanding performance, commitment to customer success, and dedication to delivering high-quality Cisco training programs across the region.
“To be recognized once was an honour beyond words, but to be bestowed this distinction again is truly humbling and a testament to the unwavering support and encouragement of those who have walked this journey with us,” said Takashi Ozawa, President & CEO of Trainocate Holdings. “We are deeply grateful for everyone who has been a part of our success. This award reflects our core values of collaboration, excellence, and customer centricity, and it inspires us to continue upholding them in everything we do.”
“Receiving the Cisco Learning Partner of the Year award for a second consecutive year is a true reflection of our team’s dedication and our unwavering pursuit of excellence,” said Khor Hee Soo, CTO of Trainocate Holdings, Managing Director for India, and Chairman for Sri Lanka and UAE. “This recognition not only celebrates the hard work of everyone at Trainocate but also reinforces our commitment to empowering individuals and organizations across the APJC region with transformative learning solutions. We are deeply grateful to Cisco for their partnership and look forward to continuing our journey of innovation and impact in the learning and development space.”
During the award ceremony held on 23 October 2024, Cisco highlighted Trainocate’s impressive achievements within the past year, including:
32% of Instructor-Led Training (ILT) seats sold in the APJC region.45% of Cisco U subscriptions sold in the APJC region.Exceptional learner satisfaction on score of 94%.
These accomplishments demonstrate Trainocate’s strong track record of delivering impactful and engaging learning experiences that help professionals achieve their career goals and organizations drive digital transformation.
As a Cisco Platinum Learning Partner, Trainocate offers a comprehensive portfolio of authorized Cisco training courses, certifications, and learning solutions. With over 29 years of experience, Trainocate is a trusted partner for organizations seeking to upskill their workforce and stay ahead of the curve in today’s rapidly evolving technology landscape.
About Trainocate Holdings
Trainocate Holdings is a leading provider of IT and professional training, offering a comprehensive range of courses and certifications across various domains.
Boasting a global presence in 22 countries (and counting!) and a commitment to excellence, Trainocate empowers individuals and organizations to achieve their full potential through continuous learning and development.
With 30+ authorized training partnerships and countless awards from leading technology vendors, you’re guaranteed learning from the industry’s elite when you #GetTrainocated.
For more information, visit Trainocate’s website www.trainocate.com.
Photo: https://mma.prnewswire.com/media/2557947/Trainocate_Wins_2024.jpg
Logo: https://mma.prnewswire.com/media/2425834/5027333/Trainocate_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/trainocate-wins-cisco-learning-partner-of-the-year—apjc-for-second-consecutive-year-302305808.html
Technology
Can Independent Physicians Survive in 2025?
Published
30 minutes agoon
November 15, 2024By
Learn How at an Exclusive Webinar on Nov. 20th Hosted by Medical Economics and Specialdocs
CHICAGO, Nov. 14, 2024 /PRNewswire/ — In healthcare change is inevitable, but for independent physicians already facing an uncertain economic forecast in 2025, the prospect of a new administration is sparking even more concern. To help decipher the implications of an ever-evolving regulatory and reimbursement landscape, Medical Economics has teamed up with Terry Bauer, CEO of concierge medicine pioneer Specialdocs Consultants, and Max Reiboldt, Chairman of leading healthcare advisory, Coker, to present an exclusive, informational webinar for physicians on November 20th. Bauer and Reiboldt bring insights gained collectively over more than a century advising physicians on career strategies, to address the headwinds that threaten to topple private medical practices, and explain why concierge medicine offers one of today’s most viable pathways to retaining independence.
CLICK HERE to register for “2025 Forecast for Physicians: Financial Headwinds, Continued Burnout, and How Concierge Medicine May Be the Cure for What Ails You” at 7 pm CST/8 pm EST on Wednesday, November 20th.
“Now representing just 22% of all practices,1 the independent physician is in danger of disappearing altogether amid unrelenting financial, professional and personal pressures,” says Bauer. “Among other challenges, rising costs to operate a traditional practice and continual cuts to Medicare reimbursements have contributed to an overall 29% downward slide in Medicare compensation over the last two decades.”2
He continues: “Yet we know that a change to our membership medicine model can prove lifesaving, restoring practice sustainability and ushering in a new era of unparalleled career satisfaction. We’ve long championed this solution for physicians in private practice, who have been consistently unappreciated for the very real value they bring to their patients and the health system.”
Adds Reiboldt: “Physicians in private practice are still a cornerstone of our healthcare system yet are facing challenges that threaten their existence. More and more physicians are affiliating with capital and/or strategic partners, which is not a bad thing but still threatens their independence and private structure.”
A number of crucial issues will be examined during the webinar. “We will approach these with sensitivity as all providers (physicians, health systems, private and public investors, et al) share in both the credit and the blame for our current state of affairs,” says Reiboldt.
Topics will include:
The new administration’s approach to lowering costs, reducing regulatory barriers to consolidation and expanding price transparency mandates for healthcare services.Future use of AI and other technologies to drive greater efficiencies, quality of care.The outlook for primary care providers and programs such as Medicare Advantage, risk-based reimbursement, quality incentives.How upcoming changes in reimbursement and regulations impact the financial viability of traditional practices.Strategies for maintaining or regaining independence as a practitioner; concierge medicine as a model offering sustainable financial security and work-life balance.
About Our Speakers
Terry Bauer is CEO of Specialdocs Consultants. With more than three decades of healthcare leadership experience, Terry has a reputation for bringing about positive change as a strategist, builder, and driver of successful, high-performance companies. Terry’s mission at Specialdocs: to elevate the profile and escalate the growth of this firm that has pioneered the transition from traditional to independent concierge medicine practices, with a focus on expanding the reach and portfolio of high-quality services provided to the company’s growing national network of exceptional physicians. Terry’s career includes a long tenure as co-founder, president, CEO, and director of Orion HealthCorp, a national physician services and management organization. He has served on the board of directors of Specialdocs since Shore Capital Partners invested in the firm in 2015, and became CEO of the company in 2016.
Max Reiboldt, CPA, is Chairman of Coker. His 45 years of work in business and industry, primarily involving healthcare providers, has given him invaluable experience. He handles strategic, tactical, financial, and management issues that health systems, physicians, and other healthcare entities and/or investors face in today’s evolving marketplace. Max understands the nuances of the healthcare industry in a dynamic age, and how healthcare organizations need to maintain viability in a highly competitive market. Whether a transitional provider or a more trailblazing healthcare entity, Max works to provide sound solutions to everyday and long-range challenges with a hands-on approach much valued by his clients. Max oversees Coker’s services as part of the Executive Committee, and maintains his passion for working with clients and organizations of all sizes.
Physician’s Advocacy Institute reportAMA 2024 Medicare Updates
Media Contact:
Mindy Kolof
mkolof@specialdocs.com
8479213271
View original content to download multimedia:https://www.prnewswire.com/news-releases/can-independent-physicians-survive-in-2025-302306453.html
SOURCE Specialdocs Consultants
Technology
Rokid Glasses: Where AI Meets AR, Rivaling Meta’s Ray-Ban in an Exclusive Unveiling at Rokid Jungle 2024
Published
30 minutes agoon
November 15, 2024By
REDWOOD CITY, Calif., Nov. 14, 2024 /PRNewswire/ — Rokid is poised to unveil its groundbreaking next-generation smart glasses, the Rokid Glasses, at the highly anticipated Rokid Jungle 2024 event, set to take place on 18 November in Hangzhou, China. Seamlessly integrating cutting-edge artificial intelligence with augmented reality, Rokid Glasses represent the pinnacle of innovation. As the most eagerly awaited event in the augmented reality calendar, Rokid Jungle 2024 is destined to be the largest and most consequential gathering of its kind on the global stage. With an impressive turnout expected of over 1,000 distinguished attendees, the event will serve as a landmark occasion, bringing together partners, visionaries, and industry leaders. The launch of the Rokid Glasses promises to elevate the smart daily experience to unprecedented heights, setting new standards in the realm of wearable technology.
Rokid Glasses: Transforming AI and AR into an Essential Daily Gadget for All
Rokid Glasses combine style, comfort, and lightweight design with intuitive, AI-powered features. Integrated with Alibaba’s Tongyi Qianwen AI, Rokid Glasses offer a range of capabilities, including object recognition, text translation, and even solving complex math problems. It can calculate the calorie content of food or provide real-time language translation, making it an indispensable tool for travelers.
Empowered by Zhi Xiaobao, Alibaba’s AI assistant, Rokid Glasses allow users to take full control of their world with simple voice commands, whether booking a ride or ordering a coffee. The advanced voiceprint recognition technology also facilitates secure payments via Alipay, ensuring a seamless and trusted connection to the user’s phone. Alipay’s cutting-edge AI audio detection technology guarantees top-tier security and fraud prevention during transactions.
A standout feature of Rokid Glasses is the ability to view message notifications directly through the glasses, effectively replacing the need for a phone screen. This functionality hints at a future where Rokid Glasses may evolve into a central hub of daily life, potentially replacing smartphones altogether as an essential tech gadget. “We’ve crafted our new glasses to redefine the user experience, bringing the world’s first AI+AR glasses to daily life,” says Misa Zhu, Founder and CEO of Rokid. “Our mission is to make high-quality AI+AR glasses accessible to everyone, and this launch marks a bold step in that direction.” True to Rokid’s ethos of Leave Nobody Behind, the Rokid Glasses bridge gaps in accessibility, usability, and comfort, ensuring that everyone can experience the transformative power of innovation.
Rokid’s Role to Impact Global Tech Arena and Its Commitments for leading AR Industry
Rokid is making significant strides in transforming the museum experience using augmented reality (AR) technology to enhance visitor engagement. By providing immersive, interactive experiences, Rokid brings historical artifacts and exhibitions to life in exciting new ways. With over 2.5 million users benefiting from its AR glasses and more than 300,000 of these users have made actual purchases and are actively engaged with the devices. Even more striking is the fact that Rokid users spend an average of 2 hours and 45 minutes daily with Rokid glasses—this not only underscores the strong appeal of Rokid’s products but also reflects the growing consumer interest in and adoption of augmented reality technology.
Rokid’s ecosystem continues to flourish, with over 6,200 registered developers, highlighting the company’s significant progress in cultivating an open and thriving ecosystem. As the race in augmented reality heats up, major players are competing for dominance in this rapidly evolving space. With AR technology expanding its global footprint, the question remains: who will emerge as the true leader in the AR industry? While the collaboration between Ray-Ban and Meta has brought new energy to the smart glasses market, Meta continues to face challenges. Despite a decade of investment in XR, VR, and AR, Meta has made strides with VR hardware like the Meta Quest but still struggles with slow user adoption and limited AR functionality.
Rokid Jungle 2024: A Decade of Breaking Boundaries in Augmented Reality
Rokid Jungle 2024 commemorates a significant milestone: Rokid’s 10th anniversary and the beginning of the next decade of AR innovation. From its founding in 2014, Rokid has maintained a relentless focus on human-computer interaction, driving the evolution of AR technology through unwavering dedication to innovation. From setting industry standards with the original Rokid Glass to the highly regarded consumer product Rokid Air, and now with the trendsetting AR Studio and AR Lite, Rokid has played a key role in propelling the AR industry forward.
With the launch of the latest Rokid Glasses, the company reaffirms its leadership in the new wave of AR technological innovation. To mark this remarkable milestone, Rokid is delighted to offer a $20 benefit on all purchases made via the official website, using the code ROKID10 at checkout. Looking ahead, Rokid is thrilled to showcase its innovations at CES 2025, where will continue to lead the charge in AR technology. Rokid looks forward to seeing you there and sharing the next chapter of this exciting journey.
Email: pr@rokid.com
Rokid Official Website https://global.rokid.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/rokid-glasses-where-ai-meets-ar-rivaling-metas-ray-ban-in-an-exclusive-unveiling-at-rokid-jungle-2024-302306452.html
SOURCE Rokid
Trainocate Wins Cisco Learning Partner of the Year – APJC for Second Consecutive Year
Can Independent Physicians Survive in 2025?
Rokid Glasses: Where AI Meets AR, Rivaling Meta’s Ray-Ban in an Exclusive Unveiling at Rokid Jungle 2024
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Peloton Unveils Holiday 2022 Creative Campaign Highlighting How Motivation Transcends Beyond the Workout
These ’90s fashion trends are making a comeback in 2017
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days ago
Decode economic ties between GBA and Colombia from a cup of coffee
-
Technology5 days ago
Stay Better in China: Tell the Beautiful China to the World
-
Technology5 days ago
LG Display Succeeds in Developing World’s First Stretchable Display that Expands by 50 Percent
-
Technology4 days ago
Cangzhou Forum Seeks to Deepen Ties Between Chinese and Central/Eastern European SMEs
-
Technology2 days ago
Aspen Aerogels, Inc. to Present at the Barclays 15th Annual Global Automotive and Mobility Tech Conference
-
Technology2 days ago
Medcrypt Expands Strategic Partnerships with BioT, Extra Security, RTI and Stratigos Security to Enhance Cybersecurity in Medical Devices
-
Technology5 days ago
The Hottest Dog Bronchial Health Supplement on Shopee in 2024
-
Coin Market5 days ago
Bitcoin breaks $79K and 'no rash action is needed,' says analyst